Evaluation of Metastasis Inhibition by ABD-IL-2 Compared to Human IL-2 in a Breast Cancer Mouse Model.
By using ABD-IL-2 at a one-third concentration compared to IL-2, we aimed to reduce administration toxicity associated with high doses of IL-2 in immunotherapy. This approach shows potential for improving IL-2-based treatments while minimizing adverse effects.
Authors
- Alireza Razavi (ORCID: https://orcid.org/0000-0002-1974-2878)
- Ahad Muhammadnejad (ORCID: https://orcid.org/0000-0002-5936-4816)
- Gholam Ali Kardar (ORCID: https://orcid.org/0000-0001-8475-0594)
- Maryam Teimouri (ORCID: https://orcid.org/0000-0002-3904-3951)
- Mir Saeed Yekaninejad
Institutions
- Motamed Cancer Institute (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-31
- DOI
- https://doi.org/10.22034/iji.2024.103157.2819
- Primary Topic
- Chemokine receptors and signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00